News for Hutchison China MediTech Limited (H7T2.F)

Published at

Mar 4, 2021 5:25 PM

by seekingalpha.com

neutral

neutral

Hutchison China MediTech Limited 2020 Q4 - Results - Earnings Call Presentation (NASDAQ:HCM)

The following slide deck was published by Hutchison China MediTech Limited in conjunction with their 2020 Q4 earnings call.

HCM.L H7T2.F

Read more →
Published at

Jan 14, 2021 11:00 AM

by benzinga.com

mixed

mixed

Chi-Med Highlights Savolitinib Clinical Data to be Presented at Virtual WCLC

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited ("Chi-Med") (Nasdaq/AIM: HCM) today announces ...

ZEGA.SG ZEGA.MU ZEGA.F ZEGA.BE ZEG.SG ZEG.MU ZEG.F ZEG.DE ZEG.BE AZNN.MX AZNCF AZN.L 1900.HK HCM.L H7T2.F

Read more →
Published at

Jan 14, 2021 11:00 AM

by markets.businessinsider.com

mixed

mixed

Chi-Med Highlights Savolitinib Clinical Data to be Presented at Virtual WCLC

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) tod...

ZEGA.SG ZEGA.MU ZEGA.F ZEGA.BE ZEG.SG ZEG.MU ZEG.F ZEG.DE ZEG.BE AZNN.MX AZNCF AZN.L AZN 1900.HK HCM.L H7T2.F

Read more →
Published at

Jan 11, 2021 2:59 AM

by markets.businessinsider.com

positive

positive

Chi-Med, Inmagene To Develop & Commercialize Portfolio Of Drug Candidates For Immunological Diseases

(RTTNews) - Hutchison China MediTech Limited (HCM) or Chi-Med and Inmagene Biopharmaceuticals have partnered to further develop four novel preclin...

HCM.L H7T2.F

Read more →

News for Hutchison China MediTech Limited (H7T2.F)

Hutchison China MediTech Limited 2020 Q4 - Results - Earnings Call Presentation (NASDAQ:HCM)

Chi-Med Highlights Savolitinib Clinical Data to be Presented at Virtual WCLC

Chi-Med Highlights Savolitinib Clinical Data to be Presented at Virtual WCLC

Chi-Med, Inmagene To Develop & Commercialize Portfolio Of Drug Candidates For Immunological Diseases